机构

• 合肥物质科学研究院 [3]

采集方式

• OAI收割 [3]

内容类型

• 期刊论文 [3]

发表日期

• 2021 [1]
• 2020 [1]
• 2017 [1]

学科主题

筛选

浏览/检索结果: 共3条，第1-3条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 Clinical outcomes of lung adenocarcinoma patients harboring uncommon epidermal growth factor receptor (EGFR) mutations treated with EGFR-tyrosine kinase inhibitors (TKIs) 期刊论文  OAI收割 ANNALS OF PALLIATIVE MEDICINE, 2021 作者:  Si, Jinfei;  Gu, Xiaodong;  Wang, Wenxian;  Ying, Shenpeng;  Song, Zhengbo   |  收藏  |  浏览/下载：85/0  |  提交时间：2022/02/14 Epidermal growth factor receptor (EGFR)  uncommon mutation  compound mutation  double uncommon mutation  lung adenocarcinoma (lung AC)   PD-L1 expression and T cells infiltration in patients with uncommon EGFR-mutant non-small cell lung cancer and the response to immunotherapy 期刊论文  OAI收割 LUNG CANCER, 2020, 卷号: 142 作者:  Chen, Kaiyan;  Cheng, Guoping;  Zhang, Fanrong;  Zhu, Guanxia;  Xu, Yanjun   |  收藏  |  浏览/下载：81/0  |  提交时间：2020/11/26 Uncommon EGFR  Non-small cell lung cancer  PD-L1  T cell  Immunotherapy   Clinical characteristics and response to tyrosine kinase inhibitors of patients with non-small cell lung cancer harboring uncommon epidermal growth factor receptor mutations 期刊论文  OAI收割 CHINESE JOURNAL OF CANCER RESEARCH, 2017, 卷号: 29 -   |  收藏  |  浏览/下载：14/0  |  提交时间：2020/10/26 EGFR MUTATIONS  GEFITINIB TREATMENT  1ST-LINE TREATMENT  OPEN-LABEL  RARE  MULTICENTER  ERLOTINIB  GENE  CHEMOTHERAPY  EFFICACY  Non-small cell lung cancer  EGFR  uncommon mutation  target therapy